Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation

被引：208

作者：

Hem, Stanley L. ^{[1
]}

HogenEsch, Harm

机构：

[1] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA

[2] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA

来源：

EXPERT REVIEW OF VACCINES | 2007年 / 6卷 / 05期

关键词：

adsorption mechanism; aluminum hydroxide adjuvant; aluminum phosphate adjuvant; antigen trapping; antigen uptake; dendritic cell maturation; isoelectric point; recruitment of antigen-presenting cells; t-cell activation; t-cell differentiation;

D O I：

10.1586/14760584.6.5.685

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Aluminum-containing adjuvants are an important component of many vaccines because they safely potentiate the immune response. The structure and properties of aluminum hydroxide adjuvant, aluminum phosphate adjuvant and alum-precipitated adjuvants are presented in this review. The major antigen adsorption mechanisms, electrostatic attraction and ligand exchange, are related to the adjuvant structure. The manner by which aluminum-containing adjuvants potentiate the immune response is related to the structure, properties of the adjuvant and adsorption mechanism. Immunopotentiation occurs through the following sequential steps: inflammation and recruitment of antigen-presenting cells, retention of antigen at the injection site, uptake of antigen, dendritic cell maturation, T-cell activation and T-cell differentiation.

引用

页码：685 / 698

页数：14

共 81 条

[1] CONTRIBUTION OF ELECTROSTATIC AND HYDROPHOBIC INTERACTIONS TO THE ADSORPTION OF PROTEINS BY ALUMINUM-CONTAINING ADJUVANTS [J].

ALSHAKHSHIR, RH ;

REGNIER, FE ;

WHITE, JL ;

HEM, SL .

VACCINE, 1995, 13 (01) :41-44

[2] Dendritic cells and the control of immunity [J].

Banchereau, J ;

Steinman, RM .

NATURE, 1998, 392 (6673) :245-252

[3] Control of adaptive immune responses by Toll-like receptors [J].

Barton, GM ;

Medzhitov, R .

CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (03) :380-383

[4] Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants [J].

Berthold, I ;

Pombo, ML ;

Wagner, L ;

Arciniega, JL .

VACCINE, 2005, 23 (16) :1993-1999

[5] DAMPs, PAMPs and alarmins: all we need to know about danger [J].

Bianchi, Marco E. .

JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 81 (01) :1-5

[6] New insights into the mechanism of IL-1β maturation [J].

Burns, K ;

Martinon, F ;

Tschopp, J .

CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (01) :26-30

[7] Stability of aluminium-containing adjuvants to autoclaving [J].

Burrell, LS ;

Lindblad, EB ;

White, JL ;

Hem, SL .

VACCINE, 1999, 17 (20-21) :2599-2603

[8] Stability of aluminium-containing adjuvants during aging at room temperature [J].

Burrell, LS ;

White, JL ;

Hem, SL .

VACCINE, 2000, 18 (21) :2188-2192

[9]

Davis HL, 1998, J IMMUNOL, V160, P870

[10] Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant [J].

DePaz, RA ;

Henderson, I ;

Advant, SJ .

VACCINE, 2005, 23 (31) :4029-4035

← 1 2 3 4 5 6 7 8 9 →